Back to Search
CHRISTINA DRAKE
Registered Nurse
NPI: 1033817556Individual
Specialties, Licenses & Credentials
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
NCT03312517COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
NCT02353299COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (14)
Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep?
PMID 31538599·J Clin Sleep Med·2019
2-rct
Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
PMID 29215384·J Clin Psychopharmacol·2018
8-other
Arousability and Fall Risk During Forced Awakenings From Nocturnal Sleep Among Healthy Males Following Administration of Zolpidem 10 mg and Doxepin 6 mg: A Randomized, Placebo-Controlled, Four-Way Crossover Trial.
PMID 28575467·Sleep·2017
8-other
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys.
PMID 26943466·Sleep·2016
7-preclinical
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs.
PMID 24904334·Front Behav Neurosci·2014
8-other
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
PMID 24680372·Lancet Neurol·2014
3-trial
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
PMID 23197752·Neurology·2012
4-observational
The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia.
PMID 22851805·Sleep·2012
4-observational
Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.
PMID 20625114·Circulation·2010
8-other
Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey.
PMID 19195928·Sleep Med·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 HOSPITAL DR
BATAVIA, OH 45103 - Phone
- (833) 510-4357
Quick Facts
- NPI
- 1033817556
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 14
Are you this provider?
Claim Your Profile